Shares in Monte dei Paschi (MPS) fell again on Monday, extending Friday's losses, signaling lingering investor doubts over ...
Obesity drugs - especially Novo Nordic's Ozempic - dominated healthcare headlines in 2024, but Matt Miskin of John Hancock ...